Truist analyst David MacDonald lowered the firm’s price target on Molina Healthcare to $365 from $380 and keeps a Buy rating on the shares as part of a broader research note on Healthcare Services names. The analyst cites the recent market moves and updates in multiples following commentary from both UnitedHealth (UNH) and Humana (HUM) around an uptick in utilization, reducing targets in Managed Care and bumping Hospital targets while remaining “broadly bullish” on both groups.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOH:
- Molina Healthcare initiated with a Neutral at UBS
- Molina Healthcare price target lowered to $349 from $380 at TD Cowen
- Molina Healthcare price target raised to $365 from $356 at Deutsche Bank
- Molina Healthcare price target raised to $350 from $347 at Credit Suisse
- Molina Healthcare boosts FY23 adj. EPS view to at least $20.25, consensus $19.70
